The Effectiveness of SGLT-2 Inhibitors vs GLP-1 Receptor Agonists in Enhancing Kidney Function and Glycemic Control for Diabetes Mellitus Patients with CKD: A Narrative Review

Introdution: Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) are highly interconnected, impacting global health. Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) offer promising benefits for glycemic control, cardiovascular...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Putu Ngurah Pradnya Wibawa, Ni Luh Putu Serly Ekayanti
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Babali Health 2026-01-01
Schriftenreihe:	Babali Nursing Research
Schlagworte:	CKD Diabetes mellitus GLP-1RA SGLT-2 inhibitors
Online-Zugang:	http://babalinursingresearch.com/index.php/BNR/article/view/506
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!